Company: SVV
Filing Date: 2025-05-13
Form Type: S-3
Source: 0001193125-25-118371
Chunk: 33

Company: Savers Value Village, Inc.
Filing Date: 2025-05-13
Form: S-3
Chunk 33
---
 appointment of management). For a description of certain potential conflicts between the Ares Funds and our other stockholders, see “Risk Factors—Risks Relating to this Offering and Ownership of Our Common
Stock—The continuing control after this offering of our company, including the right to designate individuals to be included in the slate of nominees for election to our board of directors, by the Ares Funds, whose interests may conflict with
our interests and those of other stockholders. As such, the Ares Funds may be able to continue to influence or control our affairs and policies following the completion of this offering.” For a description of the Ares Funds’ ownership
interests in us and their rights with respect to such ownership interests, including the right to designate individuals to be included in the slate of nominees for election to our board of directors, see “Selling Stockholders” in this
prospectus

S-2

supplement and the accompanying prospectus and “Description of Capital Stock” in the accompanying prospectus.

Corporate Information

Our principal executive office is located at 11400 S.E. 6th Street, Suite 125, Bellevue, WA 98004. Our website address is www.savers.com.
Information contained on, or that can be accessed through, our website is not part of and is not incorporated by reference into this prospectus supplement or the accompanying prospectus, and you should not consider information on our website to be
part of this prospectus supplement and the accompanying prospectus.

S-3

THE OFFERING

| Common stock offered by the selling stockholders | 15,000,000 shares (or 17,250,000 shares if the underwriters exercise their option to purchase additional shares in full as described below). |

| Concurrent Share Repurchase | We intend to purchase from the underwriters $20.0 million of the shares of our common stock offered in this offering, at a price per share equal to the price per share to be paid by the underwriters to the selling stockholders. Assuming a 
 repurchase price of $11.30 per share, the last reported sale price per share of our common stock on the NYSE on May 12, 2025, we would purchase 1,769,912 shares of our common stock from the underwriters in the Concurrent Share Repurchase. |

| Common stock to be outstanding after this offering and the Concurrent Share Repurchase | 155,672,051 shares (assuming, as it pertains to the Concurrent Share